Link to this page
Experimental Conditions Ontology
Last uploaded:
December 16, 2024
Jump to:
| Preferred Name | ethosuximide | |
| Synonyms |
Zarontin 3-ethyl-3-methylpyrrolidine-2,5-dione |
|
| Definitions |
Any condition in which the main influencing factor is ethosuximide, a dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. Ethosuximide is an antiepileptic used in the treatment of absence seizures and potentially myoclonic seizures, but is ineffective against tonic-clonic seizures. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0000913 |
|
| created_by |
slaulede
|
|
| creation_date |
2021-10-29T11:04:35Z
|
|
| database_cross_reference |
MESH:D005013 PMID:30408474
|
|
| definition |
Any condition in which the main influencing factor is ethosuximide, a dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. Ethosuximide is an antiepileptic used in the treatment of absence seizures and potentially myoclonic seizures, but is ineffective against tonic-clonic seizures.
|
|
| has_exact_synonym |
Zarontin 3-ethyl-3-methylpyrrolidine-2,5-dione
|
|
| has_obo_namespace |
experimental_condition_ontology
|
|
| id |
XCO:0000913
|
|
| label |
ethosuximide
|
|
| notation |
XCO:0000913
|
|
| prefLabel |
ethosuximide
|
|
| treeView | ||
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping